OptimizeRx Corporation

NASDAQ: OPRX · Real-Time Price · USD
17.59
0.26 (1.50%)
At close: Aug 14, 2025, 3:59 PM
17.35
-1.36%
After-hours: Aug 14, 2025, 07:54 PM EDT

OptimizeRx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
92.13M 71.52M 62.45M 61.29M
Cost of Revenue
32.75M 28.62M 23.48M 25.65M
Gross Profit
59.38M 42.9M 38.97M 35.64M
Operating Income
-13.71M -26.4M -12.29M 361.1K
Interest Income
329K 2.19M 852.3K 16.98K
Pretax Income
-19.39M -25.16M -11.44M 378.08K
Net Income
-20.11M -17.57M -11.44M 378.08K
Selling & General & Admin
61.27M 53.72M 49.24M 33.19M
Research & Development
n/a n/a n/a n/a
Other Expenses
11.82M 15.58M 2.02M 2.09M
Operating Expenses
73.08M 69.3M 51.26M 35.28M
Interest Expense
6.16M 1.45M n/a n/a
Selling & Marketing Expenses
n/a -4.3M n/a 5.68M
Cost & Expenses
105.83M 97.92M 74.74M 60.93M
Income Tax Expense
725K -7.6M n/a n/a
Shares Outstanding (Basic)
18.29M 17.12M 17.78M 17.23M
Shares Outstanding (Diluted)
18.29M 17.12M 17.78M 17.69M
EPS (Basic)
-1.1 -1.03 -0.64 0.02
EPS (Diluted)
-1.1 -1.03 -0.64 0.02
EBITDA
-8.9M -21.31M -9.42M 2.33M
EBIT
-13.22M -23.71M -11.44M 361.1K
Depreciation & Amortization
4.33M 2.4M 2.02M 1.97M